Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

19 treatments under study, led by Optifree Multipurpose Disinfecting Solution

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (10)

Trial Status

Completed8
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (10)

Research Network

Common Treatments

  • Optifree Multipurpose Disinfecting Solution3
  • Habitual Contact Lenses2
  • Senofilcon A Contact Lens Acuvue Oasys2
  • Fid 114675a Multipurpose Disinfecting Solution Mpds2
  • Balafilcon A Contact Lens Purevision2

Active Sponsors

  • Alcon Research10
  • Southern California College of Optometry at Marshall B. Ketchum University1

Top Investigators

Activity Timeline